Read articles from Global

August 31, 2026 by substack.com

Four countries can tell four very different nicotine stories. Some make safer alternatives visible and accessible; others restrict them while cigarettes remain easy to buy; some lose control to illicit markets; others show how smoking can fall faster with a broader harm reduction approach. These are not abstract policy experiments — they shape what real smokers can actually do. The future of nicotine policy will depend on whether governments learn from outcomes or keep defending assumptions.

August 31, 2026 by substack.com

Nicotine is usually discussed only as a problem, which leaves the public with a distorted picture of why people use it. Its potential upsides do not make it harmless or suitable for everyone, but they do help explain demand beyond addiction alone. The main public health failure comes from confusing nicotine with smoking. A more honest debate would separate the substance from combustion, acknowledge both risks and benefits, and focus policy on reducing the harms that actually kill.

August 27, 2026 by clearingtheair.eu

The new Global State of Tobacco Harm Reduction report points to a movement that continues despite resistance, denial and political discomfort. Around the world, people are moving away from cigarettes through safer nicotine products, even where policy has been slow to recognise the shift. That progress should not be ignored because it challenges older tobacco-control assumptions. Harm reduction is no longer a marginal idea; it is part of the real-world response to smoking.

August 26, 2026 by gfn.tv

Prohibition often gives the appearance of protection while moving risk somewhere harder to see. Demand for nicotine does not disappear because legal access is restricted; it shifts towards illicit supply, weaker safeguards and fewer opportunities to guide smokers away from cigarettes. Public health should be judged by outcomes, not by how strict a policy sounds. A more effective approach would reduce harm through regulation, enforcement and realistic access to safer alternatives.

August 26, 2026 by washingtonexaminer.com

FDA authorisation of lower-risk nicotine products matters because it gives smokers something more useful than fear. A credible harm reduction framework should recognise products that can reduce exposure to combustion while maintaining strong standards for evidence, marketing and youth protection. The aim is not to normalise nicotine use, but to make the path away from cigarettes more realistic for adults who still smoke. Regulation should reward products that can help reduce harm, not keep the most dangerous option as the easiest one to find.

August 26, 2026 by bbc.com

Nicotine vapes being described as one of the best chances to quit smoking should shift the tone of the debate. Adult smokers need clear advice about options that can move them away from combustible tobacco, not messaging that makes every nicotine product sound equally dangerous. Vaping is not risk-free, but its value lies in comparison with continued smoking. Public health communication should make that hierarchy understandable enough for people to use it.

August 21, 2026 by gfn.tv

A cautious shift in the nicotine debate still matters. Moving the conversation towards safer nicotine products creates space for evidence, consumer experience and the reality that many adults continue to smoke despite repeated quit attempts. Progress does not require abandoning caution; it requires applying it proportionately. The strongest public health position is one that reduces smoking-related harm while keeping regulation honest about differences in risk.

August 20, 2026 by moregoodlessharm.com

AI assistants are becoming part of how people look for health advice, including advice on smoking and vaping. That makes the quality of their answers more than a technical issue: it can shape whether smokers understand relative risk, switching and the dangers of continued combustion. Vague or overly cautious responses may feel safe, but they can leave people with a distorted view of lower-risk alternatives. Digital health information should be accurate, proportionate and clear enough to support real-world harm reduction.

August 17, 2026 by gsthr.org

In its fifth major report, the Global State of Tobacco Harm Reduction (GSTHR) estimates around 200 million people are now using safer nicotine products (SNP), equivalent to a fifth to a quarter of the global smoking population. Analysis shows a consistent pattern of increasing SNP use alongside declining smoking prevalence across 28 countries; in Sweden, Norway, Iceland, New Zealand and the UK, SNP use has overtaken smoking. Meanwhile, global policy has shifted further toward SNP restriction or bans in 2025/6. Published by Knowledge•Action•Change with funding from Global Action to End Smoking, GSTHR: A Situation Report 2026 is out now. https://gsthr.org

August 17, 2026 by gfn.tv

Consumer evidence belongs at the centre of tobacco harm reduction research. Measuring what people think, feel and do helps explain why some products support switching, why others fail, and how regulation affects behaviour outside controlled settings. Numbers alone cannot capture trust, motivation, stigma or product appeal. Better policy needs data on real consumers, not only assumptions about how they should act.